IRVINE, CA., July 25, 2023 /OrthoSpineNews/ – HippoFi, Inc. (OTCPK:ORHB) a number one healthcare expertise firm and authority in spinal biologics, centered on the event and distribution of modern biotech merchandise, is proud to announce that over the past 6 months, whereas underneath a confidential Letter of Intent in a strategic partnership, HippoFi has designed and formulated a strategic launch of the PURmarrow 360 bone marrow aspirate (BMA) gadget all through the US.
This product is a pure extension to our sturdy product line, permitting surgeons to soundly and selectively seize the extremely desired cells from a affected person’s personal BMA throughout surgical procedure. This wealthy marrow enhances the effectiveness of PUR’s merchandise by combining the stem cells, progress elements, and proteins, serving to to supercharge bone progress in spine surgical procedures and enhance affected person therapeutic.
“As a market chief in innovation, we imagine PURmarrow 360 is within the affected person’s finest curiosity, because the purity and genetic make-up of their very own dwelling cells is unmatched. PURmarrow 360 is straightforward to make use of, with out requiring centrifugation, making it simple for spine surgeons to include in each spine surgical procedure.” shared, CJ Wiggins, Govt Chairman and CEO of HippoFi.
To study extra about PUR Biologics’ full line of biologic merchandise, go to: www.PURbiologics.com
About PUR Biologics
PUR Biologics, a completely owned subsidiary of HippoFi, Inc. (OTCPK: ORHB), is a number one biologic firm dedicated to supporting surgeons and hospitals in offering the very best care for his or her sufferers. PUR Biologics’ full line of biologic merchandise at present contains superior allografts and demineralized extracellular matrices (d-ECM), modern artificial bone-forming options, cellular-derived tissues, and a way forward for patented and next-generation regenerative stem cell and progress factor-driven therapeutics for treating osteoarthritis and cartilage regeneration.
About HippoFi, Inc.
HippoFi, Inc. (OTCPK: ORHB) delivers its cutting-edge healthcare improvements and propriety applied sciences by way of an in depth gross sales channel community, whereas implementing first-to-market options within the multibillion-dollar biotech, fintech, and synthetic intelligence (AI) markets. HippoFi includes three segments: Regenerative Therapeutics, Digital Funds, and AI, and make the most of the identical buyer channels to commercialize options, drive income, and enhance affected person outcomes. HippoFi, Inc. is publicly traded underneath the image: ORHB and is headquartered in Irvine, California, USA.
For extra data, please go to: www.HippoFi.com and www.PURbiologics.com
Contact:
Jason Brown
Shareholder Communications
HippoFi, Inc.
612-209-7565
Discussion about this post